What does the arrival of major pharmaceutical research centers in Southern California mean for San Diego? Will big pharma’s quest for new pipeline products bring new investment to startups? Will big biotech bring in additional resources? Is groom-to-acquire a good thing? James Schaeffer of Merck Research Laboratories, Avi Spier of Novartis Research Foundation, and Diego Miralles of Johnson & Johnson Pharmaceutical Research and Development discuss their strategies for the coming year. More information and online registration is here.